Market Newsdesk

TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) today announced the estimated annual capital gains distributions for its open-end exchange-traded funds, mutual funds and closed-end funds (“Funds”) for the 2020 tax year end. The estimated distributions represent estimated capital gains realized by the Funds during the year.

Details of the per unit distribution amounts are as follows:

Purpose Mutual Fund Trusts	Ticker Symbol / Fund Code	Estimated Annual Capital Gains Distribution Per Unit
Purpose Gold Bullion Fund – ETF Series	KILO	$ 0.4100
Purpose Gold Bullion Fund – ETF Non-Currency Hedged Series	KILO.B	$ 0.3600
Purpose Gold Bullion Fund – ETF Non-Currency Hedged USD Series	KILO.U	$ 0.4900

The estimated annual capital gain distribution for Purpose Gold Bullion Fund will be paid in cash. ETF unitholders of record on December 29, 2020 will receive the capital gain distributions on January 8, 2021. The ex-distribution date will be December 24, 2020.

Purpose confirms that the following Funds are not expected to have annual capital gains distributions for the 2020 tax year:

Open-End Funds

Purpose Fund Corp.
Funds:

• Purpose Core Dividend Fund
• Purpose Tactical Hedged Equity Fund
• Purpose Total Return Bond Fund
• Purpose Real Estate Income Fund
• Purpose Monthly Income Fund
• Purpose Premium Yield Fund
• Purpose Premium Money Market Fund
• Purpose Canadian Financial Income Fund
• Purpose Conservative Income Fund
• Purpose Best Ideas Fund
• Purpose Diversified Real Asset Fund
• Purpose International Tactical Hedged Equity Fund
• Purpose Enhanced Dividend Fund
• Purpose Behavioural Opportunities Fund
• Purpose Core Equity Income Fund
• Purpose Tactical Asset Allocation Fund
• Purpose Canadian Equity Growth Fund
• Purpose Canadian Income Growth Fund

Purpose Mutual Funds Limited
Funds:

• Purpose Global Innovators Fund
• Purpose Global Bond Class
• Purpose Enhanced Premium Yield Fund
• Purpose Global Resource Fund
• Purpose Special Opportunities Fund
• Purpose Structured Equity Yield Portfolio
• Purpose Structured Equity Yield Portfolio 2
• Purpose Structured Equity Growth Fund

Purpose Mutual Fund Trusts

• Purpose International Dividend Fund
• Purpose US Dividend Fund
• Purpose Global Bond Fund
• Purpose High Interest Savings ETF
• Purpose US Cash Fund
• Purpose Money Market Fund
• Purpose Multi-Strategy Market Neutral Fund
• Purpose Silver Bullion Fund
• Purpose Floating Rate Income Fund
• Purpose Canadian Preferred Share Fund
• Purpose Emerging Markets Dividend Fund
• Purpose US Preferred Share Fund
• Purpose Strategic Yield Fund
• Purpose Multi-Asset Income Fund
• Purpose Marijuana Opportunities Fund
• Purpose Credit Opportunities Fund

Closed-End Funds
:

• Investment Grade Managed Duration Income Fund
• Canadian Investment Grade Preferred Share Fund
• June 2021 Investment Grade Bond Pool
• US Banks Income & Growth Fund
• Big Banc Split Corp.

OM Funds:

• Purpose Specialty Lending Trust

Please note that these are estimated amounts only
, as of
November
30
, 20
20
. Circumstances may arise which would cause these estimates to change before the Funds’ t
ax year end on December 15, 20
20
or Decem
ber 31, 20
20
, as applicable.

Purpose expects to announce the final monthly, quarterly and annual cash distributions on all Funds on or about December 15, 2020. Purpose expects to announce the final annual capital gains distribution amounts on all Funds on or about December 17, 2020 except for Purpose High Interest Savings ETF and Purpose US Cash Fund, which will be announced on or about December 31, 2020.

For Purpose Fund Corp., Purpose Mutual Funds Limited., and Big Banc Split Corp., which are mutual fund corporations, final annual capital gains distributions will be announced on or about January 29, 2021, if necessary. As of November 30, 2020, the mutual fund corporations have no expected annual capital gains distributions.

About Purpose Investments

Purpose Investments is an asset management company with more than $10 billion under management. Purpose Investments has an unrelenting focus on client-centric innovation, and offers a range of managed and quantitative investment products. Purpose Investments is led by well-known entrepreneur Som Seif and is a division of Purpose Financial, an independent technology-driven financial services company.

For further information please contact:
Matt Padanyi
Purpose Investments Inc.
Tel: (877) 789-1517
Email: [email protected]

Commissions, trailing commissions, management fees and expenses all may be associated with investment fund investments. Please read the prospectus and other disclosure documents before investing. Investment funds are not covered by the Canada Deposit Insurance Corporation or any other government deposit insurer. There can be no assurance that the full amount of your investment in a fund will be returned to you. If the securities are purchased or sold on a stock exchange, you may pay more or receive less than the current net asset value. Investment funds are not guaranteed, their values change
frequently
and past performance may not be repeated.

This press release is for information purposes only and does not constitute an offer to sell or a solicitation to buy the securities referred to herein. This press release is not for dissemination in the United States or for distribution to US news wire services.

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of JOYY Inc. (“JOYY” or the “Company”) (NASDAQ: YY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether JOYY and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On November 18, 2020, Muddy Waters Capital (“Muddy Waters”) published a report entitled “YY: You Can’t Make this Stuff Up. Well…Actually You Can.” The Muddy Waters report described JOYY as “a multibillion-dollar fraud” with “component businesses . . . a fraction of the size it reports, and . . . reported user metrics, revenues, and cash balances [that] are predominantly fraudulent.” Citing a “year-long investigation,” Muddy Waters concluded that JOYY “is about 90% fraudulent.”

On this news, JOYY’s American depositary receipt (“ADR”) price fell $26.53 per ADR, or 26.48%, to close at $73.66 per ADR on November 18, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Pinterest, Inc. (“Pinterest” or the “Company”)(NYSE: PINS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether Pinterest and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On October 31, 2019, Pinterest announced disappointing preliminary financial results for the third quarter 2019. Pinterest reported net revenue of only $279.7, versus the consensus projection of $282 million, indicating strong deceleration in the growth of its domestic user base. The Company also gave full year 2019 guidance, which it only marginally increased, indicating further deceleration in future quarters. 

On this news, Pinterest’s stock price fell $4.28 per share, or 17.02%, to close at $20.86 per share on November 1, 2019.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980

TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Jade Power Trust (“Jade Power” or the “Trust”) (TSXV:JPWR.UN) is pleased to report its third quarter 2020 financial results. All amounts are expressed in Canadian Dollars unless otherwise noted.

Highlights
¹

• Record energy generation of 123,169 MW hours (“MWh”) for the nine months ended September 30, 2020; an increase of 7,899 MWh or 7% from the nine months ended September 30, 2019.
• Energy generation of 34,713 MWh for the third quarter of 2020; an increase of 4,141 MWh or 14% from the third quarter of 2019.
• Revenue of $4.8 million for the third quarter of 2020 compared to $4.0 million for the third quarter of 2019, an increase of 21%.    Revenue of $15.5 million for the nine months ended September 30, 2020 compared to $13.0 million for the same period in 2019, an increase of 19%.
• Adjusted EBITDA² of $2.3 million or $0.01 per Unit for the third quarter of 2020, an increase of 15% from $2.1 million or $0.01 per Unit for the comparable quarter in 2019. Adjusted EBITDA of $8.4 million or $0.04 per Unit for the nine months ended September 30, 2020 compared to $6.1 million or $0.03 per Unit for the nine months ended September 30, 2019; an increase of 39%. (see reconciliation of adjusted EBITDA under “Non-IFRS Measures”)
• Operating cash flows of $0.8 million or $0.00 per Unit after changes in net working capital for the third quarter of 2020 compared to $0.2 million or $0.00 per Unit for the third quarter of 2019. Operating cash flows of $4.4 million or $0.02 per Unit after changes in net working capital for the nine months ended September 30, 2020 compared to $7.5 million or $0.03 per Unit for the nine months ended September 30, 2019. Operating cash flows for the three and nine months ended September 30, 2020 reflect higher income from earned Green Certificates (“GCs”) relative to the cash proceeds from the sale of GCs compared to the three and nine months ended September 30, 2019. (see reconciliation of adjusted Operating cash flows per Unit after changes in net working capital under “Non-IFRS Measures”)
• Net income of $0.9 million or $0.00 per Unit for the third quarter of 2020 compared to net income of $1.4 million or $0.01 per Unit for the third quarter of 2019. Net income for the comparative period included a $1.0 million unrealized foreign exchange gain relative to an unrealized foreign exchange loss of $0.1 million in the third quarter of 2020. Net income of $2.9 million or $0.01 per Unit for the nine months ended September 30, 2020 compared to $1.5 million or $0.01 per Unit for the nine months ended September 30, 2019.

J. Colter Eadie, Chief Executive Officer of Jade Power commented “We are pleased with our third quarter and year-to-date results. Operations remain on target during this pandemic; a testament to the strength of our operating model and infrastructure. Our operations remain robust and continue to perform to expectations, while our balance sheet continues to strengthen.”

For further information please contact:

Ravi Sood Chairman +1 647-987-7663 [email protected]

J. Colter Eadie Chief Executive Officer +40 736-372-724 [email protected]

Betty Soares Chief Financial Officer +1 416-803-6760 [email protected]

About
Jade
Power

The Trust, through its direct and indirect subsidiaries in Canada, the Netherlands and Romania, has been formed to acquire interests in renewable energy assets in Romania, other countries in Europe and abroad that can provide stable cash flow to the Trust and a suitable risk-adjusted return on investment. The Trust seeks to provide investors with long-term, stable distributions, while preserving the capital value of its investment portfolio through investment, principally in a range of operational assets, which generate electricity from renewable energy sources, with a particular focus on solar and hydro power. The Trust intends to qualify as a “mutual fund trust” under the Income Tax Act (Canada) (the “Tax Act”). The Trust will not be a “SIFT trust” (as defined in the Tax Act), provided that the Trust complies at all times with its investment restriction which precludes the Trust from holding any “non-portfolio property” (as defined in the Tax Act). All material information about the Trust may be found under Jade Power’s issuer profile at www.sedar.com.

Forward-Looking Statements

Statements in this press release contain forward-looking information. Such forward-looking information may be identified by words such as “anticipates”, “plans”, “proposes”, “estimates”, “intends”, “expects”, “believes”, “may” and “will”. The forward-looking statements are founded on the basis of expectations and assumptions made by the Trust. Details of the risk factors relating to Jade Power and its business are discussed under the heading “Business Risks and Uncertainties” in the Trust’s annual Management’s Discussion & Analysis for the year ended December 31, 2019, a copy of which is available on Jade Power’s SEDAR profile at www.sedar.com. Most of these factors are outside the control of the Trust. Investors are cautioned not to put undue reliance on forward-looking information. These statements speak only as of the date of this press release. Except as otherwise required by applicable securities statutes or regulation, Jade Power expressly disclaims any intent or obligation to update publicly forward-looking information, whether as a result of new information, future events or otherwise.

Neither the TSXV nor its regulation services provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

NON-IFRS MEASURES

The Trust has included certain non-IFRS measures to supplement its consolidated financial statements, which are presented in accordance with IFRS:

The following is a reconciliation of adjusted EBITDA and adjusted EBITDA per Unit:

	For the three months ende d September 30,					For the nine months ended September 30,
		2020		2019			2020			2019
Earnings (loss) for the period from continuing operations	$	882,379	$	1,444,396		$	2,853,401		$	1,488,098
Add-back:
Financing costs		382,905		382,905			2,341,541			2,106,141
Income tax expense (recovery)		35,677		(53,199	)		(54,450	)		110,961
Depreciation		963,945		526,843			2,838,554			2,706,414
Warrant revaluation loss (gain)		–		2,458			–			(242,561	)
Gain on settlement of debt		–		(107,986	)		–			(107,986	)
One-time business transaction and other expenses		50,821		–			40,980			–
Adjusted EBITDA from continuing operations	$	2,315,727	$	2,106,940		$	8,420,026		$	6,061,067
Adjusted EBITDA per Unit from continuing operations	$	0.01	$	0.01		$	0.04		$	0.03

The following is a reconciliation of operating cash flow after changes in net working capital per Unit:

				Three months ended				Nine months ended
				September 30,				September 30,
			2020		2019		2020		2019
Net used in operating activities from continuing operations		$	758,909	$	227,388	$	4,440,113	$	7,546,017
Weighted average number of Units			231,216,256		230,361,711		231,216,256		230,230,925
Operating cash flow from continuing operations per Unit		$	0.00	$	0.00	$	0.02	$	0.03

The Trust believes that these non-IFRS measures, together with measures determined in accordance with IFRS, provide investors with an improved ability to evaluate the underlying performance of the Trust.  Non-IFRS financial measures do not have any standardized meaning prescribed under IFRS, and therefore they may not be comparable to similar measures employed by other entities.  The data is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.  Management’s determination of the components of non-IFRS and additional measures are evaluated on a periodic basis influenced by new items and transactions, a review of investor uses and new regulations as applicable. Any changes to the measures are duly noted and retrospectively applied as applicable.
42582739.1

¹From continuing operations.
² Includes foreign exchange gains (losses).

HAMILTON, Ontario, Nov. 30, 2020 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare announced that the interim consolidated financial statements (“Financial Statements”) and Management’s Discussion and Analysis (“MD&A”) for the quarter ended September 30, 2020, are now available on the Company’s profile on SEDAR (www.sedar.com). The Company is also pleased to provide the following corporate update.

As previously announced, Reliq will be hosting a webinar tomorrow, December 1^st at 6:00am PST / 9:00am EST at https://bit.ly/37eU7rA. For those who are not able to attend the webinar, a recording of the webinar will be available on the Company’s website shortly after the session.   A written summary of the material updates to be presented in the webinar is also provided below.

Agenda for Webinar

1. Highlights from Q1 FY2021 interim consolidated financial statements
2. Second tranche of private placement fully subscribed
3. Outlook for Calendar Year 2021
4. Date for webinar to review Q2 FY2021 financials

1.	Q1 FY20 2 1 Financial Statements The interim consolidated financial statements for Q1 FY2021 (quarter ending September 30, 2020) have been filed on SEDAR under the Company’s profile. Highlights: As previously disclosed, Sales for the quarter decreased due to the impact of the global pandemic on the Company’s clients in South Texas and Florida. Sales for the current quarter (October 1 – December 31, 2020) have already exceeded that of Q1 FY2021 and are expected to fully recover to the level of Q4 FY2020 sales, as the Company shifted its focus to new geographies including Puerto Rico, North Texas, Ohio and others. The Company expects Sales to consistently increase month over month throughout the remainder of FY2021 and beyond. In response to the significant ongoing challenges in Florida and South Texas relating to the uncontrolled spread of COVID-19 and corresponding paralysis of the healthcare systems in these areas, in late Q4 FY2020 the Company refocused business development efforts to geographies where physician practices and home health agencies were still able to implement Reliq’s products. In Q1 FY2021, the Company signed contracts with MaxLink MD in North Texas, Diversified Health Partners in Ohio, Oregon and Washington and digiiMED, LLC, in Puerto Rico, to provide its iUGO RPM, CCM, BHI, and PCM solutions to their over 250,000 patients. The Company also launched iUGO Well in Australia and signed a contract with the University of Notre Dame Australia to provide iUGO Well to their 12,000 faculty, staff and students. Onboarding in several of these areas began in late October and has accelerated through November 2020. Onboarding with these clients is expected to continue to increase month over month through FY2021 and beyond. Subsequent to Q1 FY2021, the Company entered into a strategic alliance with iDocsWeb to offer the iUGO Care Platform to iDocsWeb’s more than 200 Skilled Nursing Facility (SNF) clients who together discharge over 50,000 patients per year, the majority of whom are eligible for Reliq’s Transitional Care Management (TCM), Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and other services. Onboarding of patients will begin in December 2020.
2.	Second Tranche of Private Placement Fully Subscribed On October 27, 2020, the Company issued 10,637,056 units at a price of $0.225 per unit for gross proceeds of $2,393,337.60 (the “Units”). Each Unit will consist of one (1) common share and one-half (1/2) of a share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will be exercisable for an additional share at a price of $0.30 for a period of two (2) years from issuance. In the event that the common shares of the Company trade at a closing price of greater than $0.50 per Share for ten (10) consecutive trading days, the Company may accelerate the expiry date of the Warrants to expire on the 30th day after the date on which such notice is given to the warrant holders. The Company is paying finder’s fees of $44,431.88 cash and 188,775 broker warrants in connection with the first tranche. The broker warrants are issued with the same terms as the Warrants described above. The Company will be closing a second tranche of the above private placement, with final closing taking place on or before December 7, 2020. The second tranche is fully subscribed. Pursuant to a price reservation form 4A filed with the TSX-V Venture Exchange on October 22, 2020, the Company will be issuing an additional 2,696,277 Units in the second tranche for gross proceeds of an additional $606,662.33.
3.	Outlook for Calendar Year 2021 The Company expects to be cashflow positive in Q1 Calendar 2021 based on the current contracts, and to reach a run rate of over $1.5 Million per quarter by the end of FY2021 (June 30, 2021). Sales are expected to increase month over month every month throughout Calendar Year 2021. Growth is expected to accelerate significantly in the latter half of Calendar 2021 as COVID-19 vaccines become widely available and COVID-associated obstacles to onboarding are eliminated. The Company intends to provide more detailed guidance in Calendar Year 2021 as the course of the global pandemic becomes clearer.
4.	Date for Next Quarterly Update Webinar The Company’s interim consolidated financial statements for Q2 FY2021 (period ending December 31, 2020) are due to be filed on or before March 1, 2021. The webinar to review the financial statements will be scheduled on or before March 2, 2021.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

About
Reliq
Health
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

For further information please contact:
Investor Relations at [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased Precigen, Inc. f/k/a Intrexon Corporation (NASDAQ: PGEN; XON) securities between May 10, 2017 and September 25, 2020 (the “Class Period”). Investors have until December 4, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

On September 25, 2020, the U.S. Securities and Exchange Commission (“SEC”) issued a cease and desist order against Precigen. The cease and desist order involved “inaccurate reports concerning the company’s purported success converting relatively inexpensive natural gas into more expensive industrial chemicals using a proprietary methane bioconversion (‘MBC’) program.” The order noted that the Company was “primarily using significantly more expensive pure methane for the relevant laboratory experiments but was indicating that the results had been achieved using natural gas.” The cease-and-desist order further stated that although the Company “pitched the MBC program privately to numerous potential business partners over the course of 2017 and 2018” and “[a] number of these potential partners performed due diligence on the MBC program including reviewing lab results and plans for commercialization. [The Company] has not yet found a partner for the MBC program.”

The complaint, filed on October 5, 2020, alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose to investors that: (1) the Company was using pure methane as feedstock for its announced yields for its methanotroph bioconversion platform instead of natural gas; (2) yields from natural gas as a feedstock were substantially lower than the aforementioned pure methane yields; (3) due to the substantial price difference between pure methane and natural gas, pure methane was not a commercially viable feedstock; (4) the Company’s financial statements for the quarter ended March 31, 2018 were false and could not be relied upon; (5) the Company had material weaknesses in its internal controls over financial reporting; (6) the Company was under investigation by the SEC since October 2018; and (7) as a result of the foregoing, defendants’ public statements were materially false and misleading at all relevant times.

If you purchased Precigen securities during the Class Period and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About
Bragar
Eagel
& Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com